Vaccines,
Journal Year:
2022,
Volume and Issue:
10(7), P. 1003 - 1003
Published: June 23, 2022
Since
its
first
description
in
November
2021,
the
SARS-CoV-2
variant
of
concern
Omicron
(B.1.1.529)
has
emerged
as
dominant
strain
COVID-19
pandemic.
To
date,
it
remains
unclear
if
boosted
vaccination
protects
against
transmission.
Using
data
from
largest
German
Public
Health
Department,
Cologne,
we
analyzed
breakthrough
infections
booster-vaccinated
infected
persons
(IP;
group
(BVG);
n
=
202)
and
fully
vaccinated,
not
SARS-COV2-positive
patients
(>3
month
after
receiving
second
dose;
unboosted,
vaccinated
(FVG);
to
close
contacts
compared
an
age-
sex-matched
unvaccinated
control
(UCG;
202).
On
average,
IPs
had
0.42
±
0.52
relation
total
number
BVG
vs.
0.57
0.44
FVG
0.56
0.43
UVG
(p
0.054).
In
median
test,
pairwise
comparison
revealed
a
significant
difference
between
both
other
groups;
no
was
found
group.
Now,
these
findings
must
be
verified
larger
samples,
considering
role
subvariants
status
contact
person.
However,
importance
booster
breaking
possible
chains
infection
immune
escape
is
obvious.
IJID Regions,
Journal Year:
2024,
Volume and Issue:
11, P. 100348 - 100348
Published: March 13, 2024
We
investigated
genetic
variations
in
the
alpha,
delta,
and
omicron
variants
of
SARS-CoV-2
their
association
with
clinical
status
treatment
outcomes
patients
coronavirus
disease
2019
(COVID-19).
MiSeq
was
used
to
sequence
genomes,
MEGA
6.6
define
nucleotide
variations.
determined
between
severity
for
variants.
BA.1.1
BA.2
lineages
variant
had
57-59
mutations,
which
is
2-2.7-fold
higher
than
that
B.1.1.7
(alpha),
B.1.617.2,
AY.57
(delta)
lineages.
found
distinct
mutations
SARS-CoV-2:
5
alpha
(C26305T,
G26558T,
G7042T,
C14120T,
C27509T);
7
delta
(C26408T,
C1403T,
C5184T,
C9891T,
T11418C,
C11514T,
C22227T);
3
C8991T,
C25810T).
Patients
a
severe
rate
23.8%,
critical
53.7%,
mortality
38.9%,
were
significantly
those
The
this
study
diversity
differed
from
strains
reported
other
countries,
producing
more
Viruses,
Journal Year:
2024,
Volume and Issue:
16(7), P. 1150 - 1150
Published: July 17, 2024
The
global
effort
to
combat
the
COVID-19
pandemic
faces
ongoing
uncertainty
with
emergence
of
Variants
Concern
featuring
numerous
mutations
on
Spike
(S)
protein.
In
particular,
Omicron
Variant
is
distinguished
by
32
mutations,
including
10
within
its
receptor-binding
domain
(RBD).
These
significantly
impact
viral
infectivity
and
efficacy
vaccines
antibodies
currently
in
use
for
therapeutic
purposes.
our
study,
we
employed
structure-based
computational
saturation
mutagenesis
approaches
predict
effects
missense
RBD
stability
binding
affinity,
comparing
them
original
Wuhan-Hu-1
strain.
Our
results
that
such
as
G431W
P507W
induce
most
substantial
destabilizations
Wuhan-Hu-1-S/Omicron-S
RBD.
Notably,
postulate
Omicron-S
exhibit
a
higher
percentage
enhancing
affinity
compared
Wuhan-S.
We
found
at
residue
positions
G447,
Y449,
F456,
F486,
S496
led
significant
changes
affinity.
summary,
findings
may
shed
light
widespread
prevalence
human
populations.
potentially
enhance
their
receptors
facilitate
increased
internalization
infected
cells,
thereby
infectivity.
This
informs
development
new
neutralizing
capable
targeting
Omicron's
immune-evading
aiding
battle
against
pandemic.
mSphere,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Jan. 23, 2023
The
antibody
responses
to
new
SARS-CoV-2
variants
that
occur
in
different
populations
remain
unclear.
In
this
study,
we
recruited
60
participants,
including
COVID-19
patients
and
CoronaVac-vaccinated
individuals,
Thailand
determined
the
dynamic
levels
of
IgG,
IgA,
IgM,
IgG
subclasses
antibodies
against
spike
protein
(S)
four
strains.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(10), P. 2132 - 2132
Published: Oct. 21, 2023
SARS-CoV-2
(Severe
Acute
Respiratory
Syndrome
Coronavirus)
has
constantly
been
evolving
into
different
forms
throughout
its
spread
in
the
population.
Emerging
variants,
predominantly
variants
of
concern
(VOCs),
could
have
an
impact
on
virus
spread,
pathogenicity,
and
diagnosis.
The
recently
emerged
“Omicron”
variant
exhibited
rapid
transmission
divergence.
spike
protein
consistently
appearing
as
mutational
hotspot
all
these
VOCs.
In
order
to
determine
a
deeper
understanding
extremely
divergent
“Omicron”,
study
amino
acid
usage
patterns
their
substitution
was
performed
compared
with
those
other
four
successful
(“Alpha”,
“Beta”,
“Gamma”,
“Delta”).
We
observed
that
distinct
pattern
distinguishes
it
from
VOCs
is
significantly
correlated
increased
hydrophobicity
proteins.
increase
non-synonymous
rate
Considering
phylogenetic
relationship,
we
hypothesized
about
functional
interdependence
between
recombination
mutation
might
resulted
shift
optimum
for
evolution
variant.
results
suggest
improved
disease
prevention
control,
more
attention
should
be
given
significant
genetic
differentiation
diversity
newly
emerging
variants.
iScience,
Journal Year:
2024,
Volume and Issue:
27(3), P. 109123 - 109123
Published: Feb. 5, 2024
Conventional
neutralizing
enzyme-linked
immunosorbent
assay
(ELISA)
systems
for
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
mimic
the
protein-protein
interaction
between
angiotensin-converting
enzyme
(ACE2)
and
receptor-binding
domain
(RBD).
However,
an
easy
rapidly
adaptative
ELISA-based
system
testing
antibodies
against
upcoming
SARS-CoV-2
variants
is
urgently
needed.
In
this
study,
we
closed
gap
by
developing
a
tANCHOR-cell-based
RBD
neutralization
that
avoids
time-consuming
protein
expression
purification
followed
coating
on
ELISA
plates.
This
cell-based
can
be
adopted
to
monitor
(NAbs)
variants.
We
show
results
obtained
with
strongly
correlate
commercially
available
surrogate
assays
NAbs.
Moreover,
technique
directly
measure
binding
cell-surface-exposed
RBDs
soluble
ACE2.
With
technique,
degree
of
antibody
escape
elicited
emerging
in
current
vaccination
regimens
determined
reliably.
PLoS Computational Biology,
Journal Year:
2024,
Volume and Issue:
20(6), P. e1012215 - e1012215
Published: June 10, 2024
New
sublineages
of
SARS-CoV-2
variants-of-concern
(VOCs)
continuously
emerge
with
mutations
in
the
spike
glycoprotein.
In
most
cases,
sublineage-defining
vary
between
VOCs.
It
is
unclear
whether
these
differences
reflect
lineage-specific
likelihoods
for
at
each
position
or
stochastic
nature
their
appearance.
Here
we
show
that
lineages
have
distinct
evolutionary
spaces
(a
probabilistic
definition
sequence
states
can
be
occupied
by
expanding
virus
subpopulations).
This
space
accurately
inferred
from
patterns
amino
acid
variability
whole-protein
level.
Robust
networks
co-variable
sites
identify
highest-likelihood
new
VOC
and
predict
remarkably
well
emergence
subvariants
resistance
to
COVID-19
therapeutics.
Our
studies
reveal
contribution
low
frequency
variant
heterologous
across
protein
accurate
prediction
changes
interest.
Microbiology Research,
Journal Year:
2024,
Volume and Issue:
15(3), P. 1334 - 1345
Published: July 27, 2024
Since
the
emergence
of
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2),
viral
spike
protein
(S)
has
become
a
target
to
describe
appropriate
epitopes
for
vaccine
development
and
carry
out
epidemiological
surveillance,
especially
regarding
variants
concern
(VOCs).
This
study
aimed
evaluate
influence
mutations
on
physicochemical
properties
S
proteins
from
prototypical
SARS-CoV-2
VOCs
detected
in
Amazonian
countries.
Using
multiple
computational
tools,
seven
(B.1.1.7/P.1/B.1.617.2/BA.1/BA.2/BA.4/BA.5)
were
identified
compared
ancestral
lineage
virus
(B).
In
all
variants,
most
amino
acids
nonpolar;
among
polar
acids,
B.1.617.2/BA.1/BA.2/BA.4/BA.5
presented
slightly
higher
proportion
basic
residues
lower
neutral
residues.
Unlike
B.1.1.7/P.1/B.1.617.2,
BA.1/BA.2
had
greater
content
secondary
structures,
such
as
α-helices
β-sheets.
Regarding
post-translational
modifications,
BA.2/BA.4/BA.5
fewer
glycosylations
phosphorylations.
Finally,
more
prominent
antigenic
propensity
N-terminal
domain
receptor-binding
B.1.617.2/BA.4/BA.5
was
observed.
conclusion,
omicron
sequence
variability
other
VOCs,
influencing
structural
aspects
that
can
potentially
modulate
its
interaction
with
cellular
receptors
recognition
by
immune
system.
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(8), P. 1787 - 1787
Published: July 25, 2022
The
main
protease
(Mpro)
of
SARS-CoV-2
is
an
appealing
target
for
the
development
antiviral
compounds,
due
to
its
critical
role
in
viral
life
cycle
and
high
conservation
among
different
coronaviruses
continuously
emerging
mutants
SARS-CoV-2.
Ferulic
acid
(FA)
a
phytochemical
with
several
health
benefits
that
abundant
plant
biomass
has
been
used
as
basis
enzymatic
or
chemical
synthesis
derivatives
improved
properties,
including
activity
against
range
viruses.
This
study
tested
54
reported
FA
their
inhibitory
potential
Mpro
by
silico
simulations.
Molecular
docking
was
performed
using
Autodock
Vina,
resulting
comparable
better
binding
affinities
14
compounds
compared
known
inhibitors
N3
GC376.
ADMET
analysis
showed
limited
bioavailability
but
significantly
solubility
enzymatically
synthesized
hits
while
druglikeness
properties
higher
toxicity
were
observed
chemically
ones.
MD
simulations
confirmed
stability
complexes
most
promising
Mpro,
highlighting
rutinoside
compound
e27
best
candidates
from
each
derivative
category.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Aug. 2, 2022
Abstract
Since
the
emergence
of
SARS-CoV-2,
five
different
variants
concern
(VOCs)
have
been
identified:
Alpha,
Beta,
Gamma,
Delta,
and
Omicron.
Due
to
confounding
factors
in
human
population,
such
as
pre-existing
immunity,
comparing
severity
disease
caused
by
VOCs
is
challenging.
Here,
we
investigate
progression
rhesus
macaque
model
upon
inoculation
with
Omicron
BA.1,
BA.2
VOCs.
Disease
macaques
inoculated
BA.1
or
was
lower
than
those
Delta
resulted
significantly
viral
loads
nasal
swabs,
bronchial
cytology
brush
samples,
lung
tissue
macaques.
Cytokines
chemokines
were
upregulated
nasosorption
samples
animals
compared
animals.
Overall,
these
data
suggests
that
macaques,
replicates
levels
VOC,
resulting
reduced
clinical
disease.
Pathogens,
Journal Year:
2022,
Volume and Issue:
11(6), P. 672 - 672
Published: June 10, 2022
Continuous
outbreaks
of
viral
diseases
in
humans
facilitates
a
need
for
the
rapid
development
test
kits
and
vaccines.
These
require
expression
systems
to
produce
pure
high
yield
target
proteins.
We
utilized
baculovirus-silkworm
system
receptor
binding
domain
(RBD)
SARS-CoV-2
spike
protein.
First,
we
had
develop
strategy
constructing
recombinant
baculovirus
RBD
expression.
For
this,
coding
region